These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25660091)

  • 1. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
    Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S
    Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Tandon S; Singh J; Sinha S; Sharma DP
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic perianal herpes successfully treated with imiquimod.
    Lestre SI; João A; Carvalho C; Serrão VV
    An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
    Deza G; Martin-Ezquerra G; Curto-Barredo L; Villar García J; Pujol RM
    J Dermatol; 2015 Dec; 42(12):1176-8. PubMed ID: 26074211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
    Barroso Dos Reis HL; Tosato Boldrini NA; da Silva Campos LC; Campos LG; Salume Costa FL; Jacomele Caldas JV; Pedras Almeida SL; Miranda AE
    Int J Infect Dis; 2020 Jun; 95():153-156. PubMed ID: 32311452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
    Gilbert J; Drehs MM; Weinberg JM
    Arch Dermatol; 2001 Aug; 137(8):1015-7. PubMed ID: 11493093
    [No Abstract]   [Full Text] [Related]  

  • 9. Vegetative chronic genital herpes with satisfactory response to imiquimod.
    Siqueira SM; Gonçalves BB; Loss JB; Estrella RR
    An Bras Dermatol; 2019; 94(2):221-223. PubMed ID: 31090830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
    Perkins N; Nisbet M; Thomas M
    Sex Transm Infect; 2011 Jun; 87(4):292-5. PubMed ID: 21406577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
    Schacker TW; Conant M; Thoming C; Stanczak T; Wang Z; Smith M
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3243-8. PubMed ID: 12234851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive and refractory genital herpes in human immunodeficiency virus-infected patient successfully treated with imiquimod: Case report and literature review.
    Camasmie HR; Barbosa C; Lupi O; Lima RB; Serra M; D'Acri AM; Martins CJ
    Indian J Dermatol Venereol Leprol; 2017; 83(2):256-259. PubMed ID: 28164895
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients.
    Nieto Rodríguez D; Sendagorta Cudós E; Rueda Carnero JM; Herranz Pinto P
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):393-397. PubMed ID: 29203034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
    Abbo L; Vincek V; Dickinson G; Shrestha N; Doblecki S; Haslett PA
    Clin Infect Dis; 2007 Feb; 44(3):e25-7. PubMed ID: 17205432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
    Yudin MH; Kaul R
    Infect Dis Obstet Gynecol; 2008; 2008():592532. PubMed ID: 18784844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotumoral herpes genitalis in a woman living with HIV: Diagnosis and treatment challenges.
    Tomaino MV; Sanchez Costantini M; Alfaro CT
    Int J STD AIDS; 2024 Apr; 35(5):405-408. PubMed ID: 38031871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune booster used to fight drug-resistant herpes.
    TreatmentUpdate; 2001 Aug; 13(4):5. PubMed ID: 11590979
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual hypertrophic genital mass lesion--a diagnostic and treatment dilemma.
    Maharaj R; Parboosing R; Moodley M; Naicker S; Ramdial PK
    J Clin Virol; 2009 Dec; 46(4):303-4. PubMed ID: 19786363
    [No Abstract]   [Full Text] [Related]  

  • 19. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.
    Sbidian E; Battistella M; Legoff J; Lafaurie M; Bézier M; Agbalika F; Simon F; Bouscarat F; Cayuela JM; Carcelain G; Houhou N; Bagot M; Molina JM; Janier M; Bachelez H
    Clin Infect Dis; 2013 Dec; 57(11):1648-55. PubMed ID: 24065320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Ghislanzoni M; Cusini M; Zerboni R; Alessi E
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.